Rachel was appointed Associate Professor of Internal Medicine at the University Medical Center Utrecht in 2006. She came from a family with an inherited tumoursyndrome and has been active in advocacy for patients with inherited kidney cancer since 2003. She researches how kidney cells are regulated and what goes wrong in the very early steps of kidney cancer. She is the Senior Medical Writer at Medicom Medical Publishers since 2019.
She has been chair of the Dutch VHL Organisation since 2009, and an international contact point for Living with Bladder or Kidney Cancer since 2010. Rachel has been Chair of the IKCC since 2014 and became CEO in January 2023. She represents the IKCC on the EAU Guidelines Committee for renal cellcarcinoma.
Updated: November 2023